Type IV renal tubular acidosis is characterised by persistent hyperkalemia alongside acidosis, and is frequently accompanied by elevated blood pressure. First-line management addresses both abnormalities together through a coordinated approach.
Reduce serum potassium toward the normal range and bring blood pressure to target — correcting both the hyperkalemia and the hypertension as primary endpoints.
Management starts with dietary potassium restriction. In addition, a thiazide diuretic class agent may serve a dual role — addressing both the elevated potassium and blood pressure simultaneously. The full sequence, agent selection, and monitoring criteria are in the complete protocol.
DOI: 10.1053/j.ajkd.2024.08.014
In addition to dietary potassium restriction, which one of the following is best next step in management?
With regard to this patient's management, chlorthalidone would treat this patient's hypertension while also lowering his potassium, so the answer to Question 9 is (b).
The severity of the hyperkalemia and the likelihood that addition of a thiazide diuretic will correct the hyperkalemia weighs against the use of potassium binders such as patiromer or sodium zirconium cyclosilicate.
View source ↗